Archives

American Liver Foundation Honors Congressman Jim Costa (D-CA) and Congressman Don Bacon (R-NE) with Congressional Champion Awards at its Liver Life Advocacy Summit in Washington, DC

B FAIRFIELD, N.J., April 24, 2026 /PRNewswire/ — American Liver Foundation’s (ALF) Liver Life Advocacy Summit was held in Washington, D.C. on April 21st and… Login to continue reading Login…

Read MoreAmerican Liver Foundation Honors Congressman Jim Costa (D-CA) and Congressman Don Bacon (R-NE) with Congressional Champion Awards at its Liver Life Advocacy Summit in Washington, DC

Miracell Demonstrates Cognition Impairment and Brain Function Improvement in Severe Alzheimer’s Patients Using ‘SMART M-CELL’-Based CD34+ Cell-Rich Autologous Blood Concentrate Therapy

B Study published in SCIE-indexed international journal Molecular Neurobiology Three intravenous infusions at four-week intervals showed benefits in cognition, brain metabolism, and structural preservation SEOUL,… Login to continue reading Login…

Read MoreMiracell Demonstrates Cognition Impairment and Brain Function Improvement in Severe Alzheimer’s Patients Using ‘SMART M-CELL’-Based CD34+ Cell-Rich Autologous Blood Concentrate Therapy

Daewoong Pharmaceutical Hosts ‘NABOTA Master Class’… Highlighting Safety Amid Growing Demand for High-Dose, Repetitive Treatments

B 74 healthcare professionals from 13 countries attended, recognizing the value of PrabotulinumtoxinA’s “Safety” Comprehensive program including anatomy sessions, proprietary injection techniques, and 1:1 hands-on… Login to continue reading Login…

Read MoreDaewoong Pharmaceutical Hosts ‘NABOTA Master Class’… Highlighting Safety Amid Growing Demand for High-Dose, Repetitive Treatments

Citius Pharmaceuticals Announces a Registered Direct Offering of $5 Million Priced At-The-Market Under Nasdaq Rules

B CRANFORD, N.J., April 24, 2026 /PRNewswire/ — Citius Pharmaceuticals Inc. (Nasdaq: CTXR) (“Citius Pharma” or the “Company”), a biopharmaceutical company dedicated to the development… Login to continue reading Login…

Read MoreCitius Pharmaceuticals Announces a Registered Direct Offering of $5 Million Priced At-The-Market Under Nasdaq Rules